CompuGroup Medical SE & Co. KGaA
CMPUYOTCHealthcare
$23.00
$-1.80(-7.26%)
Market Cap$1.2B
P/E Ratio—
52W High$27.33
52W Low$14.485
CompuGroup Medical SE & Co. KGaA (CMPUY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CMPUY · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.15B | $1.19B | $1.13B | $1.03B | $0.84B |
| Cost of Revenue | $0.19B | $0.18B | $0.17B | $0.15B | $0.12B |
| Gross Profit | $0.97B | $1.01B | $0.96B | $0.87B | $0.71B |
| Gross Margin %(computed) | 83.64% | 84.62% | 84.81% | 84.97% | 85.15% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.03B | $0.11B | $0.12B | $0.08B |
| G&A Expenses | $0.03B | $0.03B | $0.03B | $0.03B | $0.03B |
| Total Operating Expenses | $0.86B | $1.01B | $0.85B | $0.76B | $0.59B |
| Operating Income | $0.11B | $0.12B | $0.13B | $0.11B | $0.12B |
| Operating Margin %(computed) | 9.16% | 10.28% | 11.12% | 10.60% | 14.29% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.04B | $0.02B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | $0.06B | $0.07B | $0.11B | $0.10B | $0.11B |
| Income Tax Expense | $0.03B | $0.03B | $0.03B | $0.03B | $0.04B |
| Net Income | $0.03B | $0.05B | $0.07B | $0.07B | $0.07B |
| Net Margin %(computed) | 3.00% | 3.87% | 6.50% | 6.73% | 8.74% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.67 | $0.88 | $1.41 | $1.32 | $1.36 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| EBITDA | $0.21B | $0.21B | $0.23B | $0.21B | $0.19B |
| EBITDA Margin %(computed) | 17.93% | 17.92% | 20.20% | 20.87% | 22.99% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · B
Explore more CompuGroup Medical SE & Co. KGaA data
About CompuGroup Medical SE & Co. KGaA (CMPUY) Income Statement
CompuGroup Medical SE & Co. KGaA (CMPUY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, CMPUY reported revenue of $1.15B, gross profit of $0.97B (gross margin 83.64%), and net income of $0.03B — a net profit margin of 3.00%.
Frequently asked questions
CMPUY · 4 questionsCompuGroup Medical SE & Co. KGaA (CMPUY) reported revenue of $1.15B for 2024, down 2.8% year-over-year.
CMPUY revenueCMPUY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08